178 results on '"Suganami, Takayoshi"'
Search Results
2. Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages
3. Molecular mechanism of crosstalk between immune and metabolic systems in metabolic syndrome
4. Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis.
5. The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis–associated liver tumors in a novel murine model
6. Obesity accelerates hair thinning by stem cell-centric converging mechanisms
7. Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH
8. Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
9. Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled Repair
10. Imeglimin Exhibits Novel Anti-Inflammatory Effects on High-Glucose-Stimulated Mouse Microglia through ULK1-Mediated Suppression of the TXNIP–NLRP3 Axis
11. Macrophages rely on extracellular serine to suppress aberrant cytokine production
12. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis
13. Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
14. Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors
15. Hollow fiber-combined glucose-responsive gel technology as an in vivo electronics-free insulin delivery system
16. Molecular Mechanisms Underlying Obesity-Induced Chronic Inflammation
17. Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects
18. Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis
19. Pathogenesis of Non-alcoholic Steatohepatitis and Its Potential Therapeutic Strategies
20. Healthy skeletal muscle atrophy and/or metabolism via FoxOs signaling pathway protects against starvation-induced fatty liver
21. Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84
22. Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis
23. Fat/Vessel-derived Secretory Protein (Favine)/CCDC3 Is Involved in Lipid Accumulation
24. Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages
25. Taxifolin Suppresses Inflammatory Responses of High-Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP–NLRP3 Axis.
26. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
27. Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis : role of macrophages and fibroblasts in the liver
28. A Porous Reservoir-Backed Boronate Gel Microneedle for Efficient Skin Penetration and Sustained Glucose-Responsive Insulin Delivery
29. FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting
30. Ligand-Activated PPARα-Dependent DNA Demethylation Regulates the Fatty Acid β-Oxidation Genes in the Postnatal Liver
31. Dietary Supplementation With Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity
32. Boronic Acid Ligands Can Target Multiple Subpopulations of Pancreatic Cancer Stem Cells via pH-Dependent Glycan-Terminal Sialic Acid Recognition
33. Role of chronic inflammation in the pathogenesis of nonalcoholic steatohepatitis: lessons from a unique mouse model using melanocortin receptor-deficient mice
34. Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome
35. Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH
36. C-type lectin Mincle mediates cell death–triggered inflammation in acute kidney injury
37. Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus
38. Temperature-Stable Boronate Gel-Based Microneedle Technology for Self-Regulated Insulin Delivery
39. Smart Microneedle Fabricated with Silk Fibroin Combined Semi-interpenetrating Network Hydrogel for Glucose-Responsive Insulin Delivery
40. Glucose-Responsive Insulin Delivery: Microneedle-Array Patch Fabricated with Enzyme-Free Polymeric Components Capable of On-Demand Insulin Delivery (Adv. Funct. Mater. 7/2019)
41. The role of serine, a non-essential amino acid, in the production of cytokines
42. Microneedle‐Array Patch Fabricated with Enzyme‐Free Polymeric Components Capable of On‐Demand Insulin Delivery
43. Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
44. Molecular mechanism of obesity-induced ‘metabolic’ tissue remodeling
45. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis
46. Synthetic “smart gel” provides glucose-responsive insulin delivery in diabetic mice
47. The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages
48. WNK4 is an Adipogenic Factor and Its Deletion Reduces Diet-Induced Obesity in Mice
49. Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
50. Molecular mechanism underlying nutritional control of inflammatory responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.